Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126920891 | 12692089 | 1 | I | 20160601 | 20160827 | 20160827 | PER | US-ASTRAZENECA-2016SE59683 | ASTRAZENECA | 0.00 | F | Y | 113.40000 | KG | 20160827 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126920891 | 12692089 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 22200 | 2 | MG | /wk | ||||||||
| 126920891 | 12692089 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | 0 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||||
| 126920891 | 12692089 | 3 | SS | ESOMEPRAZOLE PRESCRIPTION | ESOMEPRAZOLE | 1 | Oral | 20.0MG UNKNOWN | 0 | 20 | MG | ||||||||
| 126920891 | 12692089 | 4 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | |||||||||||
| 126920891 | 12692089 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 850.0MG UNKNOWN | 0 | 850 | MG | ||||||||
| 126920891 | 12692089 | 6 | C | BENAZEPRIL HTZ | 2 | Oral | 10 MG DAILY, 10 MG/12.5 MG | 0 | |||||||||||
| 126920891 | 12692089 | 7 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 0 | 45 | MG | QD | ||||||||
| 126920891 | 12692089 | 8 | C | DICLOFENAC | DICLOFENAC | 1 | 0 | ||||||||||||
| 126920891 | 12692089 | 9 | C | MOTRIN | IBUPROFEN | 1 | 800 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126920891 | 12692089 | 1 | Type 2 diabetes mellitus |
| 126920891 | 12692089 | 2 | Diabetes mellitus |
| 126920891 | 12692089 | 3 | Gastrooesophageal reflux disease |
| 126920891 | 12692089 | 5 | Diabetes mellitus |
| 126920891 | 12692089 | 6 | Renal disorder |
| 126920891 | 12692089 | 7 | Diabetes mellitus |
| 126920891 | 12692089 | 8 | Arthralgia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126920891 | 12692089 | Cardiac murmur | |
| 126920891 | 12692089 | Injection site extravasation | |
| 126920891 | 12692089 | Injection site haemorrhage | |
| 126920891 | 12692089 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126920891 | 12692089 | 1 | 2014 | 0 | ||
| 126920891 | 12692089 | 2 | 2010 | 2014 | 0 | |
| 126920891 | 12692089 | 5 | 2003 | 0 | ||
| 126920891 | 12692089 | 6 | 2008 | 0 | ||
| 126920891 | 12692089 | 7 | 2005 | 0 |